Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Rapid and sustained control of itch and reduction in Th2 bias by dupilumab in a patient with Sézary syndrome
Oliver Steck, Nicole Bertschi, Fabian Luther, et al.
Journal of the European Academy of Dermatology and Venereology (2020) Vol. 35, Iss. 6, pp. 1331-1337
Closed Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Pruritus as a Distinctive Feature of Type 2 Inflammation
Simone Garcovich, Martina Maurelli, Paolo Gisondi, et al.
Vaccines (2021) Vol. 9, Iss. 3, pp. 303-303
Open Access | Times Cited: 119
Dupilumab in Inflammatory Skin Diseases: A Systematic Review
Henning Olbrich, Christian D. Sadik, Ralf J. Ludwig, et al.
Biomolecules (2023) Vol. 13, Iss. 4, pp. 634-634
Open Access | Times Cited: 42
Dupilumab-Associated Adverse Events During Treatment of Allergic Diseases
Anna Kychygina, Myriam Cassagne, M. Tauber, et al.
Clinical Reviews in Allergy & Immunology (2022) Vol. 62, Iss. 3, pp. 519-533
Closed Access | Times Cited: 50
Cutaneous T‐cell lymphoma following dupilumab use: a systematic review
Ariel Park, Lulu Wong, Annalise Lang, et al.
International Journal of Dermatology (2022) Vol. 62, Iss. 7, pp. 862-876
Open Access | Times Cited: 41
Dupilumab for the treatment of adult atopic dermatitis in special populations
Cataldo Patruno, Luca Potestio, Massimiliano Scalvenzi, et al.
Journal of Dermatological Treatment (2022) Vol. 33, Iss. 7, pp. 3028-3033
Closed Access | Times Cited: 33
Malignant T cells induce skin barrier defects through cytokine-mediated JAK/STAT signaling in cutaneous T-cell lymphoma
Maria Gluud, Emil M. H. Pallesen, Terkild B. Buus, et al.
Blood (2022) Vol. 141, Iss. 2, pp. 180-193
Open Access | Times Cited: 32
Role of IL-4 and IL-13 in Cutaneous T Cell Lymphoma
Roberto Mazzetto, Paola Miceli, Jacopo Tartaglia, et al.
Life (2024) Vol. 14, Iss. 2, pp. 245-245
Open Access | Times Cited: 6
Prominent Role of Type 2 Immunity in Skin Diseases: Beyond Atopic Dermatitis
Lina Belmesk, Anastasiya Muntyanu, Emmanuelle Cantin, et al.
Journal of Cutaneous Medicine and Surgery (2021) Vol. 26, Iss. 1, pp. 33-49
Open Access | Times Cited: 32
Mogamulizumab efficacy is underscored by its associated rash that mimics cutaneous T-cell lymphoma: a retrospective single-centre case series
Nicholas A. Trum, Jasmine Zain, X. Martínez, et al.
British Journal of Dermatology (2021) Vol. 186, Iss. 1, pp. 153-166
Open Access | Times Cited: 32
Pruritus: A Sensory Symptom Generated in Cutaneous Immuno-Neuronal Crosstalk
Attila Gábor Szöllősi, Attila Oláh, Erika Lisztes, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 21
Development of Cutaneous T-Cell Lymphoma Following Biologic Treatment: A Systematic Review
Lauren Schaefer, Nneka I. Comfere, Olayemi Sokumbi
American Journal of Clinical Dermatology (2023) Vol. 24, Iss. 2, pp. 153-164
Closed Access | Times Cited: 12
T cells in the skin: Lymphoma and inflammatory skin disease
Ben Roediger, Christoph Schlapbach
Journal of Allergy and Clinical Immunology (2022) Vol. 149, Iss. 4, pp. 1172-1184
Open Access | Times Cited: 17
An update on mechanisms of pruritus and their potential treatment in primary cutaneous T-cell lymphoma
Man Hu, Jörg Scheffel, Daniel Elieh Ali Komi, et al.
Clinical and Experimental Medicine (2023) Vol. 23, Iss. 8, pp. 4177-4197
Open Access | Times Cited: 9
Development of Nodular Lesions after Dupilumab Therapy in Erythrodermic Mycosis Fungoides with Interleukin-13 Receptor alpha2 Expression
Mina Hashimoto, Tomomitsu Miyagaki, Reo Komaki, et al.
Acta Dermato Venereologica (2022) Vol. 102, pp. adv00766-adv00766
Open Access | Times Cited: 14
Safety and Danger Considerations of Novel Treatments for Atopic Dermatitis in Context of Primary Cutaneous Lymphomas
Karol Kołkowski, Magdalena Trzeciak, Małgorzata Sokołowska‐Wojdyło
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13388-13388
Open Access | Times Cited: 20
Dupilumab for the treatment of recalcitrant eosinophilic dermatosis of haematologic malignancy
Roberto Maglie, Filippo Ugolini, Francesco De Logu, et al.
Journal of the European Academy of Dermatology and Venereology (2021) Vol. 35, Iss. 8
Closed Access | Times Cited: 17
The pruritogenic role of the type 2 immune response in diseases associated with chronic itch
Giuseppe Ingrasci, Zoe M. Lipman, Ahmed A. Hawash, et al.
Experimental Dermatology (2021) Vol. 30, Iss. 9, pp. 1208-1217
Open Access | Times Cited: 14
Dupilumab as a therapy option for treatment refractory mogamulizumab-associated rash
Nicholas A. Trum, Jasmine Zain, Chelsea Abad, et al.
JAAD Case Reports (2021) Vol. 14, pp. 37-42
Open Access | Times Cited: 12
Lethal anaplastic large-cell lymphoma occurring in a patient treated with dupilumab
A. Du‐Thanh, Valentin Gustave, O. Dereure
JAAD Case Reports (2021) Vol. 18, pp. 4-7
Open Access | Times Cited: 12
A Case of Sézary Syndrome in a Patient Treated with Dupilumab for Atopic Dermatitis
Kaito Muramatsu, Risa Ikutama, Toshio Hasegawa
Indian Journal of Dermatology (2024)
Open Access | Times Cited: 1
Increased Risk of Cutaneous T‐Cell Lymphoma Development after Dupilumab Use for Atopic Dermatitis
Jenna Mandel, Jaanvi Mehta, R Häfer, et al.
Dermatologic Therapy (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 1
Diagnosing mycosis fungoides after initiation of therapy with dupilumab: a case report and literature review
Di Yan, Vignesh Ramachandran, Gillian Weston, et al.
International Journal of Dermatology (2023) Vol. 62, Iss. 9
Closed Access | Times Cited: 3
Deciphering Tumor Cell Evolution in Cutaneous T-Cell Lymphomas: Distinct Differentiation Trajectories in Mycosis Fungoides and Sézary Syndrome
Tony Jiang, Simon Cao, Oleg Kruglov, et al.
Journal of Investigative Dermatology (2023) Vol. 144, Iss. 5, pp. 1088-1098
Closed Access | Times Cited: 3
Atopic Dermatitis with Multiple Comorbidities Treated with Dupilumab. A Case Report and Review of the Literature Regarding the Safety of Dupilumab
George Mitroi, Loredana Elena Stoica, George F. Mitroi, et al.
Life (2022) Vol. 12, Iss. 10, pp. 1670-1670
Open Access | Times Cited: 5
Dupilumab: Newer off-label dermatological indications and clinical implications - Part II
Aditya Kumar Bubna, Vinayak Viplav
Journal of Skin and Sexually Transmitted Diseases (2024), pp. 1-11
Open Access
Page 1 - Next Page

Scroll to top